Pharmical
ActiveFinancials · financial year 2025, abbreviated format
2025 annual accounts filed 18 days after the deadline Filed on 18 August 2026, deadline 31 July 2026 (7 months after the close on 31 December 2025, Companies Code art. 3:10). Source: NBB, 2026-00404671.
Annual accounts 2025 filed on 18-08-2026 at the NBB all 3 filings
Turnover
≈ €170,000
Estimated: probably between €92,000 and €330,000
Total assets
€1.5m▼ 6.2%
2024 · €1.6m
Net result
€98,170▲ 91.5%
2024 · €51,267
Working capital
-€241,439▲ 16.7%
2024 · -€289,856
Multi-year overview
2023 to 2025, 3 financial yearsOperating result
€30,996
▲ 204%
2025
20232025
Net result
€98,170
▲ 91.5%
2025
20232025
Equity
€309,612
▲ 46.4%
2025
20232025
Total assets
€1.5m
▼ 6.2%
2025
20232025
Debt
€1.2m
▼ 14.4%
2025
20232025
Working capital
-€241,439
▲ 16.7%
2025
20232025
Staff (FTE)
no figure
2025
20232025
Every figure per financial year
Every figure with its change against the financial year before
favourable
unfavourable
Line202320242025
Operating result-€0.02m-€0.01m€0.03m▲ 204%
Net result-€0.04m-€0.05m€0.1m▲ 91.5%
Equity€0.2m-€0.2m▲ 32.0%€0.3m▲ 46.4%
Total assets€1.5m-€1.6m▲ 2.2%€1.5m▼ 6.2%
Debt€1.4m-€1.4m▼ 1.2%€1.2m▼ 14.4%
Working capital-€0.3m--€0.3m▲ 7.8%-€0.2m▲ 16.7%
Staff (FTE)0-0
The operating result for 2025 is over 3 times that of 2024 and the highest since 2023. It is the second rise in a row.
Turnover and EBIT margin are not published. The abbreviated format does not require them. The turnover shown is an estimate from the gross margin.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €1.5m
Fixed assets
€1.5m ▼ 1.2%
Current assets
€26,645 ▼ 75.3%
Equity and liabilities €1.5m
Equity
€309,612 ▲ 46.4%
Debt
€1.2m ▼ 14.4%
Debt's share of the balance-sheet total falls from 86.6% to 79.1%. Equity is higher and debt is lower.
Key figures and ratios
EBITDA
€47,996▼
2024 · €48,367
Cash flow
€115,170▲
2024 · €89,453
Current ratio
0.10▼
2024 · 0.27
Debt to equity
3.78▼
2024 · 6.47
ROE
31.7%▲
2024 · 24.2%
ROA
6.6%▲
2024 · 3.2%
Interest coverage
1.77▲
2024 · 0.96
Debt ≤ 1 year
€268,085▼
2024 · €397,708
Debt > 1 year
€897,900▼
2024 · €964,651
Green means a favourable move, even when the figure itself falls, as with debt or debt to equity.
Investments
| Item | 2023 | 2024 | 2025 |
|---|---|---|---|
| Tangible fixed assets | €381,913 | - | - |
| Financial fixed assets | €1.8m | - | - |
| Depreciation and write-downs of the year | €30,470 | €38,186 | €17,000 |
Source: notes to the 2023 to 2025 annual accounts (statement of fixed assets)
Annual accounts
| Line | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630 | €30,470 | €38,186 | €17,000 | ▼ 55.5% |
| Other operating charges640/8 | €309 | €1,375 | €408 | ▼ 70.4% |
| Gross operating margin9900 | €8,120 | €49,742 | €48,404 | ▼ 2.7% |
| Operating profit (loss)9901 | -€22,659 | €10,181 | €30,996 | ▲ 204% |
| Financial income75/76B | €667,800 | €91,684 | €94,322 | ▲ 2.9% |
| Recurring financial income75 | €667,800 | €91,684 | €94,322 | ▲ 2.9% |
| Financial charges65/66B | €684,965 | €50,598 | €27,148 | ▼ 46.3% |
| Recurring financial charges65 | €17,165 | €50,598 | €27,148 | ▼ 46.3% |
| Non-recurring financial charges66B | €667,800 | €0 | - | - |
| Profit (loss) for the period before taxes9903 | -€39,824 | €51,267 | €98,170 | ▲ 91.5% |
| Profit (loss) for the period9904 | -€39,824 | €51,267 | €98,170 | ▲ 91.5% |
| Profit (loss) for the period to be appropriated9905 | -€39,824 | €51,267 | €98,170 | ▲ 91.5% |
| Line | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|
| Assets | ||||
| Total assets20/58 | €1.5m | €1.6m | €1.5m | ▼ 6.2% |
| Fixed assets21/28 | €1.5m | €1.5m | €1.5m | ▼ 1.2% |
| Tangible fixed assets22/27 | €0.4m | €0.3m | €0.3m | ▼ 5.4% |
| Land and buildings22 | €0.4m | €0.3m | €0.3m | ▼ 5.4% |
| Financial fixed assets28 | €1.2m | €1.2m | €1.2m | = |
| Current assets29/58 | €0.03m | €0.1m | €0.03m | ▼ 75.3% |
| Amounts receivable within one year40/41 | €0.03m | €0.09m | €0 | ▼ 100% |
| Other amounts receivable41 | €0.03m | €0.09m | €0 | ▼ 100% |
| Cash at bank and in hand54/58 | €0.008m | €0.02m | €0.03m | ▲ 64.8% |
| Equity and liabilities | ||||
| Total equity and liabilities10/49 | €1.5m | €1.6m | €1.5m | ▼ 6.2% |
| Equity10/15 | €0.2m | €0.2m | €0.3m | ▲ 46.4% |
| Contributions10/11 | €0.2m | €0.2m | €0.2m | = |
| Reserves13 | - | €0.01m | €0.1m | ▲ 858% |
| Distributable reserves133 | - | €0.01m | €0.1m | ▲ 858% |
| Profit (loss) carried forward14 | -€0.04m | €0 | - | - |
| Amounts payable17/49 | €1.4m | €1.4m | €1.2m | ▼ 14.4% |
| Amounts payable after more than one year17 | €1.0m | €1.0m | €0.9m | ▼ 6.9% |
| Financial debts170/4 | €1.0m | €1.0m | €0.9m | ▼ 6.9% |
| Amounts payable within one year42/48 | €0.3m | €0.4m | €0.3m | ▼ 32.6% |
| Current portion of amounts payable after more than one year42 | €0.06m | €0.06m | €0.07m | ▲ 2.9% |
| Financial debts43 | €0.3m | €0 | - | - |
| Credit institutions430/8 | €0.3m | €0 | - | - |
| Trade debts44 | €97 | €0.001m | €0 | ▼ 100% |
| Suppliers440/4 | €97 | €0.001m | €0 | ▼ 100% |
| Other amounts payable47/48 | - | €0.3m | €0.2m | ▼ 39.4% |
| Accrued charges and deferred income492/3 | €0.006m | €0.006m | €0.006m | = |
| Line | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|
| Profit (loss) for the period9904 | -€39,824 | €51,267 | €98,170 | ▲ 91.5% |
| + Depreciation and write-downs630 | €30,470 | €38,186 | €17,000 | ▼ 55.5% |
| Operating cash flow (approximation) | -€9,354 | €89,453 | €115,170 | ▲ 28.7% |
| Investment in fixed assets (approximation) | - | €0 | €0 | - |
| Change in cash | - | €8,176 | €10,477 | ▲ 28.1% |
A Belgian filing has no cash-flow statement. These rows are therefore an approximation, derived from the income statement and the balance-sheet moves.